Antithrombotic effects of a synthetic inhibitor of activated factor X, JTV-803, in animals.

[1]  Y. Ikeda,et al.  Antithrombotic effect of SM-20302, a nonpeptide GPIIb/IIIa antagonist, in a photochemically induced thrombosis model in guinea pigs. , 1999, Thrombosis research.

[2]  Y. Terada,et al.  DX-9065a, an Orally Active Factor Xa Inhibitor, Does not Facilitate Haemorrhage Induced by Tail Transection or Gastric Ulcer at the Effective Doses in Rat Thrombosis Model , 1999, Thrombosis and Haemostasis.

[3]  K. Mann,et al.  Evaluation of the Initiation Phase of Blood Coagulation Using Ultrasensitive Assays for Serine Proteases* , 1997, The Journal of Biological Chemistry.

[4]  C. Doutremépuich,et al.  Importance of photo activation of rose bengal for platelet activation in experimental models of photochemically induced thrombosis. , 1996, Thrombosis research.

[5]  E. Topol,et al.  Selective inhibition of factor Xa during thrombolytic therapy markedly improves coronary artery patency in a canine model of coronary thrombosis , 1996, Blood coagulation & fibrinolysis : an international journal in haemostasis and thrombosis.

[6]  J. Freedman,et al.  Control Mechanisms in Thrombin Generation , 1996, Seminars in thrombosis and hemostasis.

[7]  S. Kunitada,et al.  Species differences in anticoagulant and anti-Xa activity of DX-9065a, a highly selective factor Xa inhibitor. , 1995, Thrombosis research.

[8]  H. Ishihara,et al.  DX-9065a, an Orally Active, Specific Inhibitor of Factor Xa, Inhibits Thrombosis without Affecting Bleeding Time in Rats , 1995, Thrombosis and Haemostasis.

[9]  J. Lynch,et al.  Primary Prevention of Coronary Arterial Thrombosis with the Factor Xa Inhibitor rTAP in a Canine Electrolytic Injury Model , 1995, Thrombosis and Haemostasis.

[10]  M. Nakashima,et al.  Vessel Wall Injury and Arterial Thrombosis Induced by a Photochemical Reaction , 1995, Thrombosis and Haemostasis.

[11]  G. Vlasuk,et al.  Assembly of the prothrombinase complex enhances the inhibition of bovine factor Xa by tick anticoagulant peptide. , 1994, Biochemistry.

[12]  C. Dunwiddie,et al.  Specific factor Xa inhibition reduces restenosis after balloon angioplasty of atherosclerotic femoral arteries in rabbits. , 1994, Circulation.

[13]  B. Francis,et al.  Antithrombotic activity of recombinant tick anticoagulant peptide and heparin in a rabbit model of venous thrombosis. , 1993, Thrombosis research.

[14]  P. Schoen,et al.  Flow and the inhibition of prothrombinase by antithrombin III and heparin. , 1991, Blood.

[15]  C. Dunwiddie,et al.  Comparison of the In Vivo Anticoagulant Properties of Standard Heparin and the Highly Selective Factor Xa Inhibitors Antistasin and Tick Anticoagulant Peptide (TAP) in a Rabbit Model of Venous Thrombosis , 1991, Thrombosis and Haemostasis.

[16]  C. Dunwiddie,et al.  Purification and characterization of recombinant antistasin: a leech-derived inhibitor of coagulation factor Xa. , 1991, Archives of biochemistry and biophysics.

[17]  L. Bush,et al.  In vivo models of arterial thrombosis and thrombolysis , 1990, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[18]  R. Colman,et al.  Human platelet factor V is crosslinked to actin by FXIIIa during platelet activation by thrombin. , 1990, Thrombosis research.

[19]  H. Pelzer,et al.  Determination of Human Thrombin-Antithrombin III Complex in Plasma with an Enzyme-Linked Immunosorbent Assay , 1988, Thrombosis and Haemostasis.

[20]  I. Palacios,et al.  Acute coronary reocclusion after thrombolysis with recombinant human tissue-type plasminogen activator: prevention by a maintenance infusion. , 1986, Circulation.

[21]  R. Rosenberg,et al.  Protection of factor Xa from neutralization by the heparin-antithrombin complex. , 1983, The Journal of clinical investigation.

[22]  R. Tidwell,et al.  Strategies for anticoagulation with synthetic protease inhibitors. Xa inhibitors versus thrombin inhibitors. , 1980, Thrombosis research.

[23]  K. Mann,et al.  The contribution of bovine Factor V and Factor Va to the activity of prothrombinase. , 1979, The Journal of biological chemistry.

[24]  K. Váradi,et al.  Optimization of conditions for the catalytic effect of the factor IXa-factor VIII complex: probable role of the complex in the amplification of blood coagulation. , 1979, Thrombosis research.

[25]  J. Miletich,et al.  Properties of the factor Xa binding site on human platelets. , 1978, The Journal of biological chemistry.